Short Interest Reporting: Is Buying Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Here Good Idea?

November 23, 2016 - By Louis Casey   ·   0 Comments

Short Interest Reporting: Is Buying Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Here Good Idea?

The stock of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) registered an increase of 4.4% in short interest. ADMP’s total short interest was 1.98 million shares in November as published by FINRA. Its up 4.4% from 1.89 million shares, reported previously. With 214,200 shares average volume, it will take short sellers 9 days to cover their ADMP’s short positions. The short interest to Adamis Pharmaceuticals Corporation’s float is 13.17%. About 26,448 shares traded hands. Adamis Pharmaceuticals Corp (NASDAQ:ADMP) has declined 61.98% since April 21, 2016 and is downtrending. It has underperformed by 67.31% the S&P500.

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The company has a market cap of $63.14 million. The Firm is engaged in the development of its specialty pharmaceutical products. It currently has negative earnings. The Firm is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company .

ADMP Company Profile

Adamis Pharmaceuticals Corporation, incorporated on April 22, 2004, is a pharmaceutical company. The Firm is engaged in the development of its specialty pharmaceutical products. The Firm is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company’s product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300.

More news for Adamis Pharmaceuticals Corp (NASDAQ:ADMP) were recently published by: Marketwatch.com, which released: “/quotes/zigman/3870025/realtime” on April 25, 2011. Quotes.Wsj.com‘s article titled: “DOW JONES, A NEWS CORP COMPANY” and published on May 16, 2012 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Louis Casey


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>